Vincent Duval

Alternating high-fat diet enhances atherosclerosis by neutrophil reprogramming

Jean‐Rémi Lavillegrand, Rida Al-Rifai, Sara Thietart et al. · Nature · 2024 · 74 citations · Full text

Inflammation, Metabolic Syndrome, Cardiovascular Disease +6

Impact of Omission or Replacement of Data Below the Limit of Quantification on Parameter Estimates in a Two-Compartment Model

Vincent Duval, Mats O. Karlsson · Pharmaceutical Research · 2002 · 71 citations

Phase 1/1b dose escalation and expansion study of BEZ235, a dual PI3K/mTOR inhibitor, in patients with advanced solid tumors including patients with advanced breast cancer

Jordi Rodón, José Alejandro Pérez Fidalgo, Ian E. Krop et al. · Cancer Chemotherapy and Pharmacology · 2018 · 58 citations

Dual Pi3k/mtor Inhibitor, Phase 1/1B, Breast Oncology +10

Pharmacokinetics and Pharmacodynamics of Single Rising Intravenous Doses (0.5 mg–10 mg) and Determination of Absolute Bioavailability of the Dipeptidyl Peptidase-4 Inhibitor Linagliptin (BI 1356) in Healthy Male Subjects

Silke Retlich, Vincent Duval, Arne Ring et al. · Clinical Pharmacokinetics · 2010 · 48 citations

Molecular Pharmacology, Therapeutic Drug Monitoring, Pharmacokinetic Modeling +11

A dose-escalation study with the novel formulation of the oral pan-class I PI3K inhibitor BEZ235, solid dispersion system (SDS) sachet, in patients with advanced solid tumors.

James D. Peyton, Jordi Rodón, H. Burris et al. · Journal of Clinical Oncology · 2011 · 46 citations

Dose-escalation Study, Oncology, Pi3k Inhibitor Bez235 +12